Congress targets hidden epidemic: 12 million Americans with neglected poverty diseases

What it does

This bill authorizes the Secretary of Health and Human Services to establish an interagency task force and fund programs to study, prevent, and treat neglected diseases of poverty (parasitic and bacterial diseases like Chagas disease, dengue fever, and toxocariasis) that disproportionately affect poor Americans. It creates surveillance systems, funds health centers to screen and treat at-risk populations, supports research into new drugs and diagnostics, and establishes centers of excellence for training and research.

Why we flagged it

The bill's operative mechanism is straightforward authorization of federal grant-making and task-force coordination to address a documented public health gap affecting poor Americans. It is a standard public health authorization bill with no hidden provisions or private beneficiaries.

What the text implies

• Surveillance system may reveal higher prevalence of neglected diseases in the U.S. than currently known, potentially shifting public health priorities and resource allocation.
• Emphasis on 'affordable' therapeutics and diagnostics may signal intent to negotiate or cap pricing, which could affect pharmaceutical R&D incentives for these low-profit-margin diseases.
• Centers of excellence funding may concentrate expertise in a small number of institutions, creating geographic disparities in access to specialized care and training.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill directly funds public health infrastructure, surveillance, and treatment access for vulnerable populations living in poverty who currently lack awareness of and access to diagnosis and treatment for diseases affecting an estimated 12 million Americans. The mechanism is transparent grant-making to public health agencies and federally qualified health centers, with no private carve-outs or liability shields.

Who stands to gain

• Federally qualified health centers (grant recipients)
• State health departments (grant recipients)
• Public and nonprofit research entities (grant recipients for drug/diagnostic development)
• Academic medical centers and nonprofit research institutions (centers of excellence)

Named in the bill

Department of Health and Human Services, Centers for Disease Control and Prevention, Food and Drug Administration, National Institutes of Health, Health Resources and Services Administration, Biomedical Advanced Research and Development Authority, Department of State, Department of Agriculture, Department of Housing and Urban Development, Environmental Protection Agency, Department of Defense, Federally qualified health centers — and 1 more

Where it stands

• Sep 24, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Sep 24, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.